Clinical pharmacology of new antiepileptic drugs

Neurology

Volumn 55, Issue 11 SUPPL. 3, 2000, Pages

  Willmore, L J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM; GANAXOLONE; LOSIGAMONE; NEW DRUG; PREGABALIN; REMACEMIDE; RUFINAMIDE; STIRIPENTOL; ZONISAMIDE;

ARTICLE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG PROTEIN BINDING; DRUG SAFETY; EPILEPSY; HUMAN; PRIORITY JOURNAL; SIDE EFFECT;

ANTICONVULSANTS; EPILEPSY; HUMANS;

EID: 0034642350     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Descriptive epidemiology of epilepsy: Contributions of population-based studies from Rochester, Minnesota
2. Zonisamide enhances slow sodium inactivation in myxicola
3. Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex
4. Clinical pharmacology and therapeutic drug monitoring of zonisamide
5. Effects of zonisamide (AD-810 on tungstic acid gel-induced thalamic generalized seizures and conjugated estrogen-induced cortical spike-wave discharges in cats
6. 3-Sulfamoyl methyl-1,2-benzisoxazole, a new type of anticonvulsant drug: Electroencephalographic profile
7. Population analysis of the dose-dependent pharmacokinetics of zonisamide in epileptic patients
8. Factors influencing serum concentration of zonisamide in epileptic patients
9. Progress report on new antiepileptic drugs: A summary of the fourth Eilat Conference (EILAT IV)
10. Antiepileptic drugs in development: Prospects for the near future
11. Efficacy and safety of zonisamide: Results of a multicenter study
12. Zonisamide: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in epilepsy
13. Zonisamide
14. Stiripentol
15. The metabolic fate of stiripentol in man
16. The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine
17. New antiepileptic drugs - An explosion of activity
18. Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic children
19. New anticonvulsant drugs: Focus on flunarizine, fosphenytoin, midazolam and stiripentol
20. Stiripentol: Efficacy and tolerability in children with epilepsy
21. Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain
22. The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata
23. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
24. In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent
25. Photosensitive epilepsy: A model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam
26. 'Proof of principle' study to evaluate efficacy and safety of levetiracetam (1500 mg bid) monotherapy in patients with refractory focal epilepsy
27. Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity
28. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3α-hydroxy-3β-methyl-5α-pregnan-20-one), a selective, high-affinity, steroid modulator of the γ-aminobutyric acid(A) receptor
29. Remacemide hydrochloride: A novel antiepileptic agent
30. Progress report on new antiepileptic drugs: A summary of the Third Eilat Conference
31. Effects of the anticonvulsant losigamone and its isomers on the GABAa receptor system
32. Anticonvulsant effects of tetronic acid derivatives on picrotoxin induced epileptiform activity in rat hippocampal slices
33. Effects of the tetronic acid derivatives AO-33 (losigamone) and AO-78 on epileptiform activity and on stimulus-induced calcium concentration changes in rat hippocampal slices
34. Losigamone
35. Comparison of the effects of losigamone and its isomers on maximal electroshock-induced epileptiform activity in slices of the rat temporal cortex
36. 3-Substituted GABA analogs with central nervous system activity: A review
37. 14C]-labelled losigamone and enantiomers after oral administration to healthy subjects
38. Losigamone interactions with antiepileptic drugs in healthy volunteers
39. Pharmacokinetics of losigamone, a new antiepileptic drug, in healthy male volunteers
40. Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin
41. The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteers